T2 Biosystms Stock Beneish M Score
| TTOO Stock | USD 2.97 0.17 5.41% |
TTOO | Beneish M Score |
At this time, it appears that T2 Biosystms is an unlikely manipulator. The earnings manipulation may begin if T2 Biosystms' top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by T2 Biosystms executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of T2 Biosystms' earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.24
Beneish M Score - Unlikely Manipulator
T2 Biosystms Beneish M-Score Indicator Trends
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if T2 Biosystms' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Net Receivables | 2.2 M | 1.4 M |
|
| |||||
| Total Revenue | 9.8 M | 7.2 M |
|
| |||||
| Total Assets | 43.7 M | 34.8 M |
|
| |||||
| Total Current Assets | 35.3 M | 25.1 M |
|
| |||||
| Non Current Assets Total | 11.6 M | 9.7 M |
|
| |||||
| Property Plant Equipment | 9.5 M | 15.3 M |
|
| |||||
| Depreciation And Amortization | 843.9 K | 859 K |
|
| |||||
| Selling General Administrative | 26 M | 26.1 M |
|
| |||||
| Total Current Liabilities | 59 M | 56.2 M |
|
| |||||
| Non Current Liabilities Total | 6.3 M | 6.7 M |
|
| |||||
| Short Term Debt | 45 M | 42.9 M |
|
| |||||
| Long Term Debt | 29.1 M | 57.1 M |
|
|
T2 Biosystms Beneish M-Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between T2 Biosystms' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards T2 Biosystms in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find T2 Biosystms' degree of accounting gimmicks and manipulations.
Click cells to compare fundamentals
About T2 Biosystms Beneish M Score
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Depreciation And Amortization |
|
T2 Biosystms Earnings Manipulation Drivers
Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as T2 Biosystms. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Receivables | 2.8M | 5.1M | 5.1M | 2.2M | 1.4M | 2.2M | |
| Total Revenue | 8.3M | 18.1M | 28.1M | 22.3M | 7.2M | 9.8M | |
| Total Assets | 28.5M | 79.1M | 60.5M | 34.4M | 34.8M | 43.7M | |
| Total Current Assets | 18.9M | 53.6M | 44.4M | 19.4M | 25.1M | 35.3M | |
| Net Debt | 33.7M | 39.0M | 34.9M | 48.9M | 33.8M | 35.5M | |
| Short Term Debt | 42.9M | 1.2M | 1.2M | 1.4M | 42.9M | 45.0M | |
| Operating Income | (52.1M) | (41.4M) | (43.0M) | (55.5M) | (47.2M) | (49.5M) | |
| Investments | (761K) | (35.5M) | 25.3M | 9.7M | (202K) | (212.1K) | |
| Gross Profit Margin | (1.01) | (0.17) | 0.26 | 0.0523 | (1.23) | (1.17) |
About T2 Biosystms Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze T2 Biosystms's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T2 Biosystms using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T2 Biosystms based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.
Currently Active Assets on Macroaxis
| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink | |
| XLM | Stellar | |
| CRO | Cronos |
Check out T2 Biosystms Piotroski F Score and T2 Biosystms Altman Z Score analysis. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.19) | Revenue Per Share 2.756 | Quarterly Revenue Growth (0.69) | Return On Assets (0.85) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.